XML 29 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Cash flows from operating activities:    
Net income $ 105,180 $ 148,809
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, depletion and amortization 260,982 204,777
Accretion expense 24,926 23,134
Deferred income tax provision 59,573 97,926
Settlement of asset retirement obligations (47,211) (52,543)
Non-cash stock compensation expense 6,800 4,492
Excess tax benefits (882) (1,490)
Non-cash derivative income (584) (4,337)
Loss on early extinguishment of debt   607
Non-cash interest expense 9,068 1,412
Other non-cash (income) expense 16 (1,362)
Change in current income taxes (3,240) (21,710)
Increase in accounts receivable (15,832) (17,117)
Increase in other current assets (2,456) (185)
Decrease in inventory 136 1,606
Increase in accounts payable 6,116 2,679
Increase (decrease) in other current liabilities (24,301) 3,604
Other (4,378) (1,889)
Net cash provided by (used in) operating activities 373,913 388,413
Cash flows from investing activities:    
Investment in oil and gas properties (445,311) (430,711)
Proceeds from sale of oil and gas properties, net of expenses 403 7,692
Sale of fixed assets 134  
Investment in fixed and other assets (3,998) (1,788)
Net cash used in investing activities (448,772) (424,807)
Cash flows from financing activities:    
Proceeds from bank borrowings 25,000  
Repayments of bank borrowings (70,000)  
Proceeds from issuance of senior convertible notes 300,000  
Financing costs of senior convertible notes (8,855)  
Proceeds from Sold Warrants 40,170  
Payments for Purchased Call Options (70,830)  
Deferred financing costs   (4,017)
Excess tax benefits 882 1,490
Net payments for share based compensation (3,773) (2,581)
Net cash provided by (used in) financing activities 212,594 (5,108)
Net change in cash and cash equivalents 137,735 (41,502)
Cash and cash equivalents, beginning of period 38,451 106,956
Cash and cash equivalents, end of period $ 176,186 $ 65,454